{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:29:12Z","timestamp":1793035752649,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ijantimicag.2021.106409","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T13:32:04Z","timestamp":1627651924000},"page":"106409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-4420","authenticated-orcid":false,"given":"Jeroen","family":"Schouten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-9748","authenticated-orcid":false,"given":"Jan","family":"De Waele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2822-8122","authenticated-orcid":false,"given":"Christian","family":"Lanckohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Koulenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2043-7133","authenticated-orcid":false,"given":"Nisrine","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Sj\u00f6vall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souha S.","family":"Kanj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2021.106409_bib0001","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cmi.2020.04.024","article-title":"COVID-19: don't neglect antimicrobial stewardship principles!","volume":"26","author":"Huttner","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0002","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/23744235.2020.1839672","article-title":"Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in the Netherlands","volume":"53","author":"Karami","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0003","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0004","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0005","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00134-015-4030-8","article-title":"Understanding antibiotic stewardship for the critically ill","volume":"42","author":"De Waele","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0006","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/cc11853","article-title":"Antimicrobial stewardship programs: mandatory for all ICUs","volume":"16","author":"Kollef","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0007","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00134-020-06278-x","article-title":"Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?","volume":"47","author":"De Waele","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0008","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0009","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jac\/dkaa475","article-title":"An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London","volume":"76","author":"Wang","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0011","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1007\/s00330-020-07018-x","article-title":"Comparison of the computed tomography findings in COVID-19 and other viral pneumonia in immunocompetent adults: a systematic review and meta-analysis","volume":"30","author":"Altmayer","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0012","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","article-title":"Nine-i Investigators. Diagnosis of severe respiratory infections in immunocompromised patients","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0013","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/cid\/ciz545","article-title":"Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis","volume":"70","author":"Kamat","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106051","article-title":"Procalcitonin levels in COVID-19 patients","volume":"56","author":"Hu","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620937175","article-title":"C-reactive protein, procalcitonin, d-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis","volume":"14","author":"Huang","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13756-020-00819-1","article-title":"Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis","volume":"9","author":"Li","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0017","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.21037\/jtd.2016.12.89","article-title":"Duration of antibiotic therapy in the intensive care unit","volume":"8","author":"Zilahi","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041295","article-title":"Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study","volume":"10","author":"Hodges","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0019","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cca.2020.03.004","article-title":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"505","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0020","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/thoraxjnl-2020-214896","article-title":"Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia","volume":"75","author":"Gautam","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0021","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/cid\/ciz545","article-title":"Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis","volume":"70","author":"Kamat","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0022","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1515\/cclm-2018-1181","article-title":"Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use","volume":"57","author":"Schuetz","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0023","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units: a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0024","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0025","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0026","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1017\/ice.2020.1291","article-title":"Changes in antimicrobial utilization during the coronavirus disease 2019 (COVID-19) pandemic after implementation of a multispecialty clinical guidance team","volume":"42","author":"Staub","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0027","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jgar.2020.07.017","article-title":"Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit","volume":"22","author":"Heesom","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0028","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.7861\/clinmed.2020-0614","article-title":"Use of procalcitonin for antibiotic stewardship in patients with COVID-19: a quality improvement project in a district general hospital","volume":"21","author":"Peters","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0029","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1017\/ice.2020.1329","article-title":"Antibiotic prescribing patterns for coronavirus disease 2019 (COVID-19) in two emergency departments with rapid procalcitonin","volume":"42","author":"Pulia","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s13054-020-03291-w","article-title":"Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?","volume":"24","author":"van Berkel","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0031","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0032","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0033","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s13054-020-03364-w","article-title":"Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study","volume":"24","author":"Kooistra","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0034","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/jmv.26698","article-title":"Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection","volume":"93","author":"Hariyanto","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J Mycol Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0036","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM200307313490519","article-title":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids","volume":"349","author":"Wang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/modpathol.3800247","article-title":"Pulmonary pathology of severe acute respiratory syndrome in Toronto","volume":"18","author":"Hwang","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0038","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0039","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","article-title":"Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment","volume":"31","author":"Vanderbeke","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0041","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13054-020-03046-7","article-title":"Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series","volume":"24","author":"Wang","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0042","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0043","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0044","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/myc.13185","article-title":"Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: an observational study from New York City","volume":"63","author":"Mitaka","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0046","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jof6020079","article-title":"Azole-resistant COVID-19-associated pulmonary aspergillosis in an immunocompetent host: a case report","volume":"6","author":"Meijer","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0047","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/pathogens10020157","article-title":"First Candida auris outbreak during a COVID-19 pandemic in a tertiary-care center in Lebanon","volume":"10","author":"Allaw","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0048","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0049","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cmi.2020.07.010","article-title":"Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients","volume":"26","author":"Lamoth","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0050","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0051","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0052","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"AspICU Study Investigators. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0053","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13054-015-1140-1","article-title":"Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study","volume":"19","author":"Delsuc","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0054","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/myc.13213","article-title":"Invasive pulmonary aspergillosis in the COVID-19 era: an expected new entity","volume":"64","author":"Machado","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0055","article-title":"Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study","author":"Bartoletti","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0056","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0057","article-title":"A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU","author":"White","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0058","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/diagnostics10100807","article-title":"Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: a systematic review of the literature","volume":"10","author":"Apostolopoulou","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0059","doi-asserted-by":"crossref","first-page":"790e1","DOI":"10.1016\/j.cmi.2020.12.005","article-title":"Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort","volume":"27","author":"Delli\u00e8re","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s13054-020-03417-0","article-title":"Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease","volume":"24","author":"Razazi","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0061","doi-asserted-by":"crossref","first-page":"e2144","DOI":"10.1002\/rmv.2144","article-title":"Why the elderly appear to be more severely affected by COVID-19: the potential role of immunosenescence and CMV","volume":"30","author":"Kadambari","year":"2020","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0062","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12979-020-00185-x","article-title":"The ancient and the new\u2019: is there an interaction between cytomegalovirus and SARS-CoV-2 infection?","volume":"17","author":"Moss","year":"2020","journal-title":"Immun Ageing"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0063","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4933-7-7","article-title":"Factors that may impact on immunosenescence: an appraisal","volume":"7","author":"Ongr\u00e1di","year":"2010","journal-title":"Immun Ageing"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0064","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4933-6-10","article-title":"Mechanisms of immunosenescence","volume":"6","author":"Caruso","year":"2009","journal-title":"Immun Ageing"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coviro.2020.07.013","article-title":"Cytomegalovirus as an immunomodulator across the lifespan","volume":"44","author":"Semmes","year":"2020","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0066","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/clim.1998.4638","article-title":"Role of cytomegalovirus in the T cell changes seen in elderly individuals","volume":"90","author":"Looney","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0067","first-page":"92","article-title":"Possible causes of disparities in the risk and outcomes of COVID-19: cytomegalovirus and aged immune phenotype","volume":"6","author":"Smith","year":"2020","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0068","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.coi.2009.05.012","article-title":"Biomarkers of human immunosenescence: impact of cytomegalovirus infection","volume":"21","author":"Derhovanessian","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0069","article-title":"A case of coinfection with SARS-COV-2 and cytomegalovirus in the era of COVID-19","volume":"7","author":"D'Ardes","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0070","article-title":"COVID-19 and cytomegalovirus co-infection: a challenging case of a critically ill patient with gastrointestinal symptoms","volume":"7","author":"Amaral","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0071","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3201\/eid1706.101057","article-title":"Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy","volume":"17","author":"van Duin","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0072","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13613-016-0207-8","article-title":"Cytomegalovirus infection in immunocompetent critically ill adults: literature review","volume":"6","author":"Al-Omari","year":"2016","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0073","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.127.1.233","article-title":"Cytomegalovirus infection in critically ill patients: associated factors and consequences","volume":"127","author":"Jaber","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0074","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0075","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/CCM.0b013e31819ffea6","article-title":"Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients","volume":"37","author":"Chiche","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0076","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.CCM.0000257325.88144.30","article-title":"A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients","volume":"35","author":"Papazian","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0077","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12879-018-3195-5","article-title":"Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis","volume":"18","author":"Li","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0078","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s13054-020-03252-3","article-title":"Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients","volume":"24","author":"Le Balc'h","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0079","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijid.2020.12.051","article-title":"San Matteo Pavia COVID-19 Task Force. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count","volume":"104","author":"Paolucci","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000556","article-title":"Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19","volume":"8","author":"Carll","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0081","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.060","article-title":"Cytomegalovirus-induced gastrointestinal bleeding and pancreatitis complicating severe COVID-19 pneumonia: a paradigmatic case","volume":"12","author":"Marchi","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0082","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jamainternmed.2017.0895","article-title":"Safety and efficacy of antiviral therapy for prevention of cytomegalovirus reactivation in immunocompetent critically ill patients: a randomized clinical trial","volume":"177","author":"Cowley","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0083","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0084","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient\u2014concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0085","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s00134-020-06211-2","article-title":"Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study","volume":"46","author":"Xie","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0086","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042398","article-title":"Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study","volume":"10","author":"Jim\u00e9nez","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0087","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","article-title":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study","volume":"47","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0088","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s12879-020-05423-7","article-title":"Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series","volume":"20","author":"Yao","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241544","article-title":"Characteristics and outcomes of hospitalised patients with acute kidney injury and COVID-19","volume":"15","author":"Hamilton","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0090","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1159\/000511160","article-title":"Acute kidney injury in COVID-19 patients: an inner city hospital experience and policy implications","volume":"51","author":"Zahid","year":"2020","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0091","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00134-020-06153-9","article-title":"Acute kidney injury in critically ill patients with COVID-19","volume":"46","author":"Gabarre","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0092","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243710","article-title":"Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: a prospective observational cohort study","volume":"15","author":"Thomson","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0093","first-page":"1079","article-title":"Epidemiology of augmented renal clearance in mixed ICU patients","volume":"81","author":"De Waele","year":"2015","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0094","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s13054-020-03058-3","article-title":"Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!","volume":"24","author":"Tomasa-Irriguible","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0095","first-page":"387","article-title":"Preliminary therapeutic drug monitoring data of \u03b2-lactams in critically ill patients with SARS-CoV-2 infection","volume":"39","author":"Novy","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0096","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jgar.2020.02.022","article-title":"ESCMID Study Group for Infections in the Elderly (ESGIE). Considerations for the optimal management of antibiotic therapy in elderly patients","volume":"22","author":"Falcone","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0097","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4140\/TCP.n.2008.324","article-title":"Pharmacokinetic and pharmacodynamic alterations in the geriatric patient","volume":"23","author":"Delafuente","year":"2008","journal-title":"Consult Pharm"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0098","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-030-59261-5_28","article-title":"Acute kidney injury and COVID-19: a scoping review and meta-analysis","volume":"1321","author":"Jafari-Oori","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0099","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12603-020-1550-x","article-title":"Clinical characteristics and short-term outcomes of acute kidney injury missed diagnosis in older patients with severe COVID-19 in intensive care unit","volume":"25","author":"Li","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.ijantimicag.2021.106409_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104866","article-title":"Concerns about pharmacokinetic (PK) and pharmacokinetic\u2013pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection","volume":"181","author":"Venisse","year":"2020","journal-title":"Antiviral Res"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921001813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921001813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:41:39Z","timestamp":1760377299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857921001813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0924857921001813"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106409","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106409"}}